Privia Health Group (PRVA) just released third quarter and nine month results, reporting higher sales and net income than a year earlier. This gives investors fresh numbers to reassess the stock.
That earnings beat lands on a stock that has shown mixed momentum. The 1 day share price return of 4.33% and 1 month share price return of 9.54% contrast with a year to date share price decline of 4.52%, and a 1 year total shareholder return that is down 10.47%. This suggests the recent move may reflect investors reassessing Privia Health Group after a tougher stretch.
Scan how Privia Health Group compares with other healthcare stocks showing earnings momentum by reviewing the hand picked 38 healthcare AI stocks.
For Privia Health Group, a strong quarter and a sharp bounce in the share price still sit against a weaker one year record. Investors may now be asking whether most of the recovery has already played out, or if the valuation still leaves room on the table.
Most Popular Narrative: 29% Undervalued
Against the last close at $22.40, the most followed narrative on Privia Health Group puts fair value at $31.47, implying the market price sits well below that estimate and that investors are still debating how much of the earnings story to factor in.
Continued operating leverage and use of AI across workflows, reflected in adjusted EBITDA growth of 29% in Q2 2026 and EBITDA to care margin ratios above 28%, indicate potential for further margin expansion that can support higher net margins even if practice collections grow at a more moderate rate.
See why 8 investors see Privia Health Group as 29% undervalued.
Result: Fair Value of $31.47 (UNDERVALUED)
Still, the Privia Health Group story can be knocked off course if insider selling continues or if shared savings cash flows arrive later than analysts currently model.
Find out about the key risks to this Privia Health Group narrative.
Another View: Privia Health Group On Earnings Multiples
The story changes when you switch from fair value models to a simple P/E check. Privia Health Group trades on a P/E of 101.7x, versus about 27.3x for peers and 24.8x for the wider US Healthcare sector, while the fair ratio points to 31.1x.
This gap means the stock carries a lot of expectations in its current earnings multiple, even with high quality profits and fast earnings growth. If the market leans closer to the fair ratio over time, pricing could shift quite differently from the narrative built around future cash flows.
To see what the numbers say about this price in more detail, take a look at the valuation breakdown See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Conflicted by the mix of rich earnings multiples and a bullish fair value story around Privia Health Group? Take a closer look yourself and pressure test the optimism by reviewing the 4 key rewards.
Looking for more investment ideas beyond Privia Health Group?
Do not stop your research with Privia Health Group alone. Broader opportunity often hides where fewer investors are looking, so widen your search and stack the odds in your favor.
- Target stocks with strong cash generation and supportive valuations by reviewing a curated set of potential bargains through the 35 high quality undervalued stocks.
- Prioritize resilience and support more stable investing by focusing on companies flagged in the 31 resilient stocks with low risk scores.
- Hunt for underfollowed opportunities with solid fundamentals by scanning the 19 high quality undiscovered gems.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com